American Journal of Kidney Diseases
Volume 50, Issue 3 , Pages 404-411, September 2007

Body Mass Index and Mortality in CKD

  • Magdalena Madero, MD

      Affiliations

    • Department of Medicine, Division of Nephrology, Tufts-New England Medical Center, Boston, MA
    • ,
  • Mark J. Sarnak, MD

      Affiliations

    • Department of Medicine, Division of Nephrology, Tufts-New England Medical Center, Boston, MA
    • ,
  • Xuelei Wang, MS

      Affiliations

    • Department of Biostatistics and Epidemiology, Cleveland Clinic Foundation, Cleveland, OH
    • ,
  • Carmen Castaneda Sceppa, MD

      Affiliations

    • Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, MA
    • ,
  • Tom Greene, PhD

      Affiliations

    • Division of Clinical Epidemiology, University of Utah, Salt Lake City, UT
    • ,
  • Gerald J. Beck, PhD

      Affiliations

    • Department of Biostatistics and Epidemiology, Cleveland Clinic Foundation, Cleveland, OH
    • ,
  • John W. Kusek, PhD

      Affiliations

    • National Institutes of Health, Bethesda, MD
    • ,
  • Allan J. Collins, MD

      Affiliations

    • Division of Nephrology, Hennepin County Medical Center, Minneapolis, MN.
    • ,
  • Andrew S. Levey, MD

      Affiliations

    • Department of Medicine, Division of Nephrology, Tufts-New England Medical Center, Boston, MA
    • ,
  • Vandana Menon, MD

      Affiliations

    • Department of Medicine, Division of Nephrology, Tufts-New England Medical Center, Boston, MA
    • Corresponding Author InformationAddress correspondence to Vandana Menon, MD, Tufts-New England Medical Center, Division of Nephrology, 750 Washington St, NEMC #391, Boston, MA 02111.

Received 13 November 2006; accepted 12 June 2007. published online 07 August 2007.

Background

Greater body mass index (BMI) is associated with worse survival in the general population, but appears to confer a survival advantage in patients with kidney failure treated by hemodialysis. Data are limited on the relationship of BMI with mortality in patients in the earlier stages of chronic kidney disease (CKD).

Study Design

Cohort study.

Setting & Participants

The Modification of Diet in Renal Disease (MDRD) Study examined the effects of dietary protein restriction and blood pressure control on progression of kidney disease. This analysis includes 1,759 subjects.

Predictor

BMI.

Outcomes & Measurements

Cox models were used to evaluate the relationship of quartiles of BMI with all-cause and cardiovascular disease (CVD) mortality.

Results

Mean GFR and BMI were 39 ± 21 (SD) mL/min/1.73 m2 and 27.1 ± 4.7 kg/m2, respectively. During a mean follow-up of 10 years, there were 453 deaths (26%), including 272 deaths (16%) from CVD. In unadjusted Cox models, quartiles 3 (hazard ratio [HR], 1.45; 95% confidence interval [CI], 1.11 to 1.90) and 4 (HR, 1.58; 95% CI, 1.21 to 2.06) were associated with increased risk of all-cause mortality compared with quartile 1. Adjustment for demographic, CVD, and kidney disease risk factors and randomization status attenuated this relationship for quartiles 3 (HR, 0.81; 95% CI, 0.60 to 1.09) and 4 (HR, 0.83; 95% CI, 0.61 to 1.20). In unadjusted Cox models, quartiles 3 (HR, 1.66; 95% CI, 1.17 to 2.36) and 4 (HR, 1.63; 95% CI, 1.15 to 2.33) were associated with increased risk of CVD mortality. Multivariable adjustment attenuated this relationship for quartiles 3 (HR, 0.92; 95% CI, 0.63 to 1.36) and 4 (HR, 0.85; 95% CI, 0.57 to 1.27).

Limitations

Primary analyses were based on single measurement of BMI. Because the MDRD Study cohort included relatively young white subjects with predominantly nondiabetic CKD, results may not be generalizable to all patients with CKD.

Conclusions

In this cohort of subjects with predominantly nondiabetic CKD, BMI does not appear to be an independent predictor of all-cause or CVD mortality.

Index Words: Kidney disease, outcomes, cardiovascular mortality

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Because an author of this manuscript is an editor for AJKD, the peer-review and decision-making processes were handled entirely by an outside editor, Paul Muntner, PhD, MHS, Tulane University, who served as Acting Editor-in-Chief. Details of the journal’s procedures for potential editor conflicts are given in the Editorial Policies section of the AJKD website.

 Originally published online as doi: 10.1053/j.ajkd.2007.06.004 on August 1, 2007.

PII: S0272-6386(07)00929-8

doi:10.1053/j.ajkd.2007.06.004

American Journal of Kidney Diseases
Volume 50, Issue 3 , Pages 404-411, September 2007

Article Tools

* Image Usage & Resolution